Status:
COMPLETED
Determination of Serum Trace Element and Physical Activity Levels in COVID-19
Lead Sponsor:
Izmir Bakircay University
Collaborating Sponsors:
Cigli Regional Training Hospital
Muğla Sıtkı Koçman University
Conditions:
Covid19
Eligibility:
All Genders
35-65 years
Brief Summary
The pathogenesis of COVID-19, which is caused by the coronavirus species, which has become a global health problem affecting the lives of billions of people worldwide and is a member of the Betacorona...
Detailed Description
Coronavirus disease 2019 (COVID-19), also known as Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), is caused by a coronavirus strain that has become a global health problem by affecting ...
Eligibility Criteria
Inclusion
- Having a diagnosis of COVID-19 for Group I,
- Not having any chronic diseases for Group II,
Exclusion
- Having been taking trace element supplements for the last 2 weeks
- Patients who do not require hospitalization for Group I,
- Patients with a diagnosis of kidney failure and/or heart failure for Group I,
- Patients who are pregnant for Group I
Key Trial Info
Start Date :
January 6 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 15 2021
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04694716
Start Date
January 6 2021
End Date
August 15 2021
Last Update
August 31 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kadirhan Ozdemir
Izmir, Turkey (Türkiye), 06580